A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis
Clinical trial NCT01853033 · COMPLETED
Trial details
- NCT number
- NCT01853033
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2014-05-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.